Aligos Therapeutics, Inc. held its Annual Meeting on July 20, 2023 where stockholders voted on two proposals and elected three Class III directors. Also, Ernst & Young LLP were ratified as the company's independent accounting firm for the fiscal year ending December 31, 2023.